Copyright
©The Author(s) 2021.
Artif Intell Gastrointest Endosc. Aug 28, 2021; 2(4): 95-102
Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.95
Published online Aug 28, 2021. doi: 10.37126/aige.v2.i4.95
Section | Requirements |
Method | |
Origin of dataset and description of the acquisition process | |
Pre-processing methods | |
Definition of ground truth | |
Split of data set and should include a training, validation and test set. A clear statement that the test set is not used to tune hyperparameters or in the selection of the model | |
Method and architecture used, whether it is pretrained or not, and what dataset it is pretrained on | |
Full technical detail should be included in supplementary files | |
Statement of post-selection analyses and why these are conducted | |
Results | |
A complete report of all results including but not restricted to AUC, sensitivity, specificity, accuracy and kappa value for the overall model's performance and not for selected tasks | |
Discussion | |
Risks of overfitting and bias | |
Generalisability and cautions to take | |
Clinical implementation |
- Citation: Lo B, Burisch J. Artificial intelligence assisted assessment of endoscopic disease activity in inflammatory bowel disease. Artif Intell Gastrointest Endosc 2021; 2(4): 95-102
- URL: https://www.wjgnet.com/2689-7164/full/v2/i4/95.htm
- DOI: https://dx.doi.org/10.37126/aige.v2.i4.95